tiprankstipranks
Trending News
More News >

Dhingra Kapil Insider Profile

4 Followers
Dhingra Kapil, Director at Five Prime Therapeutics, holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 0.00 shares in Replimune Group (Ticker: REPL), holds ― shares in Black Diamond Therapeutics (Ticker: BDTX). Most recently, Dhingra Kapil ― shares of Five Prime Therapeutics on ― for an estimated value of ―.
tipranks
Dhingra Kapil

Dhingra Kapil
Five Prime Therapeutics (FPRX)
Director

Not Ranked
Dhingra Kapil has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Dhingra Kapil does not currently own shares as a corporate insider.
A breakdown of Dhingra Kapil's holdings

Insider Roles

Replimune Group
(REPL)
Director
Black Diamond Therapeutics
(BDTX)
Director
Roles that Dhingra Kapil holds in companies

Most Profitable Insider Trade

Stock:
Replimune Group
(REPL)
Rating:Informative Sell
Date:Dec 11, 2025 - Today
Return:-3.10%
The most profitable trade made by Dhingra Kapil

Dhingra Kapil's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FPRX
Five Prime Therapeutics
$0.00
Replimune Group
Dec 11, 2025
Director
Uninformative Buy
5.55K
$0.00
Black Diamond Therapeutics
Director
CRGX
CARGO Therapeutics, Inc.
LVTX
LAVA Therapeutics
Nov 17, 2025
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Dhingra Kapil's performance on stock

Dhingra Kapil insider profile FAQ

What is the percentage of profitable transactions made by Dhingra Kapil?
The percentage of profitable transactions made by Dhingra Kapil is ―.
    What is the average return per transaction made by Dhingra Kapil?
    The average return per transaction made by Dhingra Kapil is ―.
      What stocks does Dhingra Kapil hold?
      Dhingra Kapil holds: FPRX, REPL, BDTX, CRGX, LVTX stocks.
        What was Dhingra Kapil’s latest transaction?
        Dhingra Kapil latest transaction was an Uninformative Buy of ―.
          What was Dhingra Kapil's most profitable transaction?
          Dhingra Kapil’s most profitable transaction was an Informative Sell of REPL stock on December 11, 2025. The return on the trade was -3.10%.
            What is Dhingra Kapil's role in Five Prime Therapeutics?
            Dhingra Kapil's role in Five Prime Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.